Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2052 ARTÍCULOS , VIENDO DEL 1816 AL 1830

Electroacupuncture ameliorates neuroinflammation in animal models

Xin YY, Wang JX, Xu AJ.

Acupunct Med. 2022 Oct;40(5):474-483. doi: 10.1177/09645284221076515. Epub 2022 Mar 1.

Animal models in the study of Alzheimer's disease and Parkinson's disease: A historical perspective

Banerjee R, Rai A, Iyer SM, Narwal S, Tare M.

Animal Model Exp Med. 2022 Feb;5(1):27-37. doi: 10.1002/ame2.12209. Epub 2022 Jan 27.

Caring for patients with cognitive dysfunction, fluctuations and dementia caused by Parkinson's disease

Halhouli O, Zhang Q, Aldridge GM.

Prog Brain Res. 2022;269(1):407-434. doi: 10.1016/bs.pbr.2022.01.018. Epub 2022 Feb 9.

"Focused Ultrasound-mediated Drug Delivery in Humans - a Path Towards Translation in Neurodegenerative Diseases"

Wasielewska JM, White AR.

Pharm Res. 2022 Mar;39(3):427-439. doi: 10.1007/s11095-022-03185-2. Epub 2022 Mar 7.

Is There Any Link between Cognitive Impairment and Gut Microbiota? A Systematic Review

Angoorani P, Ejtahed HS, Siadat SD, Sharifi F, Larijani B.

Gerontology. 2022;68(11):1201-1213. doi: 10.1159/000522381. Epub 2022 Mar 9.

Pharmacological considerations for treating neuroinflammation with curcumin in Alzheimer's disease

Zhou X, Venigalla M, Raju R, Münch G.

J Neural Transm (Vienna). 2022 Jun;129(5-6):755-771. doi: 10.1007/s00702-022-02480-x. Epub 2022 Mar 16.

Modifying the diet and gut microbiota to prevent and manage neurodegenerative diseases

Gates EJ, Bernath AK, Klegeris A.

Rev Neurosci. 2022 Mar 21;33(7):767-787. doi: 10.1515/revneuro-2021-0146. Print 2022 Oct 26.

A Review on the Arylpiperazine Derivatives as Potential Therapeutics for the Treatment of Various Neurological Disorders

Kumar B, Kumar N, Thakur A, Kumar V, Kumar R, Kumar V.

Curr Drug Targets. 2022;23(7):729-751. doi: 10.2174/1389450123666220117104038.

Propagation of tau and α-synuclein in the brain: therapeutic potential of the glymphatic system

Lopes DM, Llewellyn SK, Harrison IF.

Transl Neurodegener. 2022 Mar 21;11(1):19. doi: 10.1186/s40035-022-00293-2.

Inflammation in dementia with Lewy bodies

Amin J, Erskine D, Donaghy PC, Surendranathan A, Swann P, Kunicki AP, Boche D, Holmes C, McKeith IG, O'Brien JT, Teeling JL, Thomas AJ.

Neurobiol Dis. 2022 Jun 15;168:105698. doi: 10.1016/j.nbd.2022.105698. Epub 2022 Mar 18.

The clinical approach to the identification of higher-order visual dysfunction in neurodegenerative disease

Pelak VS.

Curr Neurol Neurosci Rep. 2022 Apr;22(4):229-242. doi: 10.1007/s11910-022-01186-7. Epub 2022 Mar 23.

Epigallocatechin-3-Gallate (EGCG): New Therapeutic Perspectives for Neuroprotection, Aging, and Neuroinflammation for the Modern Age

Payne A, Nahashon S, Taka E, Adinew GM, Soliman KFA.

Biomolecules. 2022 Feb 25;12(3):371. doi: 10.3390/biom12030371.

Endogenous Human Proteins Interfering with Amyloid Formation

Gharibyan AL, Wasana Jayaweera S, Lehmann M, Anan I, Olofsson A.

Biomolecules. 2022 Mar 14;12(3):446. doi: 10.3390/biom12030446.

Role of miRNAs in Neurodegeneration: From Disease Cause to Tools of Biomarker Discovery and Therapeutics

Roy B, Lee E, Li T, Rampersaud M.

Genes (Basel). 2022 Feb 25;13(3):425. doi: 10.3390/genes13030425.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias